Breast cancer research unit

Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you accept. The CBCRU aims to transform the patient clinical care pathway by translating cutting-edge scientific advances into treating and managing breast cancer more precisely for each individual patient and their families. Our purpose-built consulting rooms, integrated laboratory, and specially trained staff allow us to offer breast cancer patients the opportunity to participate in pioneering research studies alongside their NHS treatment. Our goal is to improve outcomes for future breast cancer patients, whilst making participation in research as beneficial and easy to understand as possible for those diagnosed with breast cancer today.

The test, which helps guide treatment decisions, was not as good at predicting the risk of death from breast cancer for Blacks as for Whites, a new study has found. The findings highlight the need for greater racial diversity in research studies. The drug abemaciclib Verzenio may be a new treatment option for people with the most common type of breast cancer, with new study findings suggesting that it can reduce the risk of the cancer returning. Experts said the findings support routinely offering fertility preservation to patients who want it. Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium. A heart-related event, like a heart attack, may make breast cancer grow faster, a new study suggests.

NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease. MRI magnetic resonance imaging , ultrasound , and clinical breast exams are also used to detect breast cancer, but not as routine screening tools.

Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.